Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label (abrocitinib). Show all posts
Showing posts with label (abrocitinib). Show all posts
Monday, March 7, 2022

FDA Approves Cibinqo (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis

›
Pfizer Inc. (NYSE: PFE) announced  the United States (U.S.) Food and Drug Administration (FDA) approval of   Cibinqo  (abrocitinib), an oral...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.